BMJ 1996;312:935-939 (13 April)

Papers

Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years

Moshe S Weintraub, head, department of internal medicine C,a Itamar Grosskopf, instructor, department of medicine C,a Toby Rassin, instructor, department of medicine E,a Hylton Miller, head, coronary catheterisation unit,a Gideon Charach, instructor, department of medicine C,a Heschi H Rotmensch, senior lecturer, department of medicine C,a Meir Liron, head, department of medicine E,a Ardon Rubinstein, head, unit of lipid metabolism,a Adrian Iaina, head, department of nephrology a

a Tel Aviv-Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Correspondence and requests for reprints to: Dr Weintraub.

Abstract

Objective: To test the hypothesis that subjects who clear chylomicron remnants slowly from plasma may be at higher risk of coronary artery disease than indicated by their fasting plasma lipid concentrations.
Design: Case control study over three years.
Setting: An 800 bed general municipal hospital.
Subjects: 85 normolipidaemic patients with coronary artery disease selected prospectively and matched with 85 normolipidaemic subjects with normal coronary arteries on angiography.
Interventions: All subjects were given a vitamin A fat loading test which specifically labels intestinal lipoproteins with retinyl palmitate.
Main outcome measure: Postprandial lipoprotein metabolism.
Results: The area below the chylomicron remnant retinyl palmitate curve was significantly increased in the coronary artery disease group as compared with the controls (mean 23.4 (SD 15.0) v 15.3 (8.9) µmol/l.h; 95% confidence interval of difference 4.37 to 11.82).
Conclusions: Normolipidaemic patients with coronary artery disease had significantly higher concentrations of chylomicron remnants in plasma than normolipidaemic subjects with normal coronary vessels. This may explain the mechanism underlying the susceptibility to atherosclerosis of coronary artery disease patients with normal fasting lipid values. As diet and drugs can ameliorate the accumulation of postprandial lipoproteins in plasma, the concentration of chylomicron remnants should be measured in patients at high risk of coronary artery disease.

Key messages

  • Key messages

  • The atherogenic effect of postprandial lipoproteins is hypothesised to be inversely related to their metabolic capacity

  • Patients with coronary artery disease have decreased metabolic capacity of chylomicron remnants as compared with subjects with normal coronary arteries

  • An ensuing postprandial dyslipidaemia may exist in patients with coronary artery disease who have normal fasting lipid values

  • A vitamin A fat loading test may be useful in identifying these patients


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Su, J. W., Lambert, J. E., Clandinin, M. T., Proctor, S. D. (2009). Impaired Postprandial Metabolism of Apolipoprotein B48-Containing Remnant Particles in Normolipidemic Subjects With Brittle Type 1 Diabetes. Diabetes Care 32: e21-e21 [Full text]  
  • Proctor, S. D., Mamo, J. C.L. (2003). Intimal Retention of Cholesterol Derived From Apolipoprotein B100- and Apolipoprotein B48-Containing Lipoproteins in Carotid Arteries of Watanabe Heritable Hyperlipidemic Rabbits. Arterioscler. Thromb. Vasc. Bio. 23: 1595-1600 [Abstract] [Full text]  
  • Yli-Jokipii, K. M., Schwab, U. S., Tahvonen, R. L., Kurvinen, J.-P., Mykkanen, H. M., Kallio, H. P. T. (2002). Triacylglycerol Molecular Weight and to a Lesser Extent, Fatty Acid Positional Distribution, Affect Chylomicron Triacylglycerol Composition in Women. J. Nutr. 132: 924-929 [Abstract] [Full text]  
  • Verges, B., Guerci, B., Durlach, V., Galland-Jos, C., Paul, J. L., Lagrost, L., Gambert, P. (2001). Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects. J. Lipid Res. 42: 2021-2029 [Abstract] [Full text]  
  • Yli-Jokipii, K., Kallio, H., Schwab, U., Mykkanen, H., Kurvinen, J.-P., Savolainen, M. J., Tahvonen, R. (2001). Effects of palm oil and transesterified palm oil on chylomicron and VLDL triacylglycerol structures and postprandial lipid response. J. Lipid Res. 42: 1618-1625 [Abstract] [Full text]  
  • Halkes, C.J.M., van Dijk, H., de Jaegere, P.P.T., Plokker, H.W.M., van der Helm, Y., Erkelens, D. W., Castro Cabezas, M. (2001). Postprandial Increase of Complement Component 3 in Normolipidemic Patients With Coronary Artery Disease: Effects of Expanded-Dose Simvastatin. Arterioscler. Thromb. Vasc. Bio. 21: 1526-1530 [Abstract] [Full text]  
  • van Wijk, J. P., Cabezas, M. C., Halkes, C. J., Erkelens, D W. (2001). Effects of different nutrient intakes on daytime triacylglycerolemia in healthy, normolipemic, free-living men. Am. J. Clin. Nutr. 74: 171-178 [Abstract] [Full text]  
  • Nestel, P. J., Shige, H., Pomeroy, S., Cehun, M., Chin-Dusting, J. (2001). Post-prandial remnant lipids impair arterial compliance. J Am Coll Cardiol 37: 1929-1935 [Abstract] [Full text]  
  • Santos, R. D., Ventura, L. I., Sposito, A. C., Schreiber, R., Ramires, J. A.F., Maranhao, R. C. (2001). The effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia. Cardiovasc Res 49: 456-465 [Abstract] [Full text]  
  • Malkova, D., Evans, R. D., Frayn, K. N., Humphreys, S. M., Jones, P. R. M., Hardman, A. E. (2000). Prior exercise and postprandial substrate extraction across the human leg. Am. J. Physiol. Endocrinol. Metab. 279: E1020-E1028 [Abstract] [Full text]  
  • Summers, L. K. M., Fielding, B. A., Herd, S. L., Ilic, V., Clark, M. L., Quinlan, P. T., Frayn, K. N. (1999). Use of structured triacylglycerols containing predominantly stearic and oleic acids to probe early events in metabolic processing of dietary fat. J. Lipid Res. 40: 1890-1898 [Abstract] [Full text]  
  • Cohn, J. S., Marcoux, C., Davignon, J. (1999). Detection, Quantification, and Characterization of Potentially Atherogenic Triglyceride-Rich Remnant Lipoproteins. Arterioscler. Thromb. Vasc. Bio. 19: 2474-2486 [Abstract] [Full text]  
  • Hadjadj, S., Paul, J.-L., Meyer, L., Durlach, V., Vergès, B., Ziegler, O., Drouin, P., Guerci, B. (1999). Delayed Changes in Postprandial Lipid in Young Normolipidemic Men after a Nocturnal Vitamin A Oral Fat Load Test. J. Nutr. 129: 1649-1655 [Abstract] [Full text]  
  • Weintraub, M., Grosskopf, I., Trostanesky, Y., Charach, G., Rubinstein, A., Stern, N. (1999). Thyroxine Replacement Therapy Enhances Clearance of Chylomicron Remnants in Patients with Hypothyroidism. J. Clin. Endocrinol. Metab. 84: 2532-2536 [Abstract] [Full text]  
  • Burnett, J. R., Barrett, P. H. R., Vicini, P., Miller, D. B., Telford, D. E., Kleinstiver, S. J., Huff, M. W. (1998). The HMG-CoA Reductase Inhibitor Atorvastatin Increases the Fractional Clearance Rate of Postprandial Triglyceride-Rich Lipoproteins in Miniature Pigs. Arterioscler. Thromb. Vasc. Bio. 18: 1906-1914 [Abstract] [Full text]  
  • Chung, B. H., Franklin, F., Cho, B. H. S., Segrest, J. P., Hart, K., Darnell, B. E. (1998). Potencies of Lipoproteins in Fasting and Postprandial Plasma to Accept Additional Cholesterol Molecules Released From Cell Membranes. Arterioscler. Thromb. Vasc. Bio. 18: 1217-1230 [Abstract] [Full text]  
  • Björkegren, J., Karpe, F., Milne, R. W., Hamsten, A. (1998). Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma. J. Lipid Res. 39: 1412-1420 [Abstract] [Full text]  
  • (1996). CLEARANCE OF CHYLOMICRON REMNANTS: ANOTHER CARDIOVASCULAR RISK FACTOR?. JWatch General 1996: 6-6 [Full text]  
Access jobs at BMJ Careers
Whats new online at Student BMJ